Envoy Medical Inc

Envoy Medical Inc(COCH)股票分析

$0.690

-0.039 (-5.58%)收盤時

Loading chart…
High
0.759
Open
0.759
VWAP
0.71
Vol
49.04K
Mkt Cap
44.88M
Low
0.690
Amount
34.97K
EV/EBITDA, TTM
-1.12

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

AI analysis of Envoy Medical Inc (COCH)

hold

Currently, Envoy Medical Inc (COCH) is not a strong buy due to its low current price of $0.69, a significantly negative RSI of 25.366, and a concerning 1-year change of -46.50%. While analysts have a price target of $2, indicating potential upside, the company's ongoing losses and negative gross margins raise substantial risks.

估值指標

The current forward P/E ratio for Envoy Medical Inc (COCH) is 0.00, compared to its 5-year average forward P/E of -1.83.

Forward P/E

Overvalued
5Y Average P/E
-1.83
Current P/E
0.00
高估
-0.18
低估
-3.47

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-1.23
Current EV/EBITDA
-1.12
高估
0.71
低估
-3.16

Forward P/S

Fair
5Y Average P/S
109.88
Current P/S
182.00
高估
201.14
低估
18.62

Alphio AI Price Scenarios for COCH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%COCH

$1.15

情境價格

B

Base

Base · 50%COCH

$1.10

情境價格

B

Bear

Bear · 25%COCH

$1.10

情境價格

事件時間軸

2026-06-02 (ET)

08:50:00

Envoy Medical Signs Media Deal with New to The Street

2025-12-18 (ET)

17:30:00

Envoy Medical Files to Sell Class A Common Stock

2024-11-14 (ET)

07:42:28

Envoy Medical reports Q3 EPS (37c) vs. 13c last year.

2024-11-01 (ET)

08:05:27

Envoy Medical receives FDA approval to initiate study for hearing device

2024-10-24 (ET)

08:27:06

Envoy Medical supports ITEM Coalition letter to CMS on hearing devices

資訊

COCH FAQ — answered by Alphio AI

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Currently, Envoy Medical Inc (COCH) is not a strong buy due to its low current price of $0.69, a significantly negative RSI of 25.366, and a concerning 1-year change of -46.50%. While analysts have a price target of $2, indicating potential upside, the company's ongoing losses and negative gross margins raise substantial risks.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始